Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1056/NEJM197010152831607 | DOI Listing |
Insects
September 2024
Laboratory of Medical Zoology, Department of Microbiology, University of Massachusetts, Amherst, MA 01003, USA.
Appl Environ Microbiol
September 2024
Department of Ecology, Evolution, and Environmental Biology, Columbia University, New York, New York, USA.
Unlabelled: Tick-borne pathogen emergence is dependent on the abundance and distribution of competent hosts in the environment. ticks are generalist feeders, and their pathogen infection prevalence depends on their relative feeding on local competent and non-competent hosts. The ability to determine what host a larval life stage tick fed on can help predict infection prevalence, emergence, and spread of certain tick-borne pathogens and the risks posed to public health.
View Article and Find Full Text PDFCurr Opin Infect Dis
October 2024
Harvard Medical School, Massachusetts General Hospital, Infectious Disease Division, Boston, Massachusetts, USA.
Infect Immun
July 2024
Department of Developmental, Molecular, and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, USA.
Human babesiosis is a malaria-like illness caused by protozoan parasites of the genus . is responsible for most cases of human babesiosis in the United States, particularly in the Northeast and the Upper Midwest. is primarily transmitted to humans through the bite of infected deer ticks but also through the transfusion of blood components, particularly red blood cells.
View Article and Find Full Text PDFClin Infect Dis
July 2024
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
Background: Relapsing babesiosis often occurs in highly immunocompromised patients and has been attributed to the acquisition of resistance against drugs commonly used for treatment such as atovaquone, azithromycin, and clindamycin. Tafenoquine, which is approved for malaria prophylaxis and presumptive antirelapse treatment of Plasmodium vivax malaria, has shown activity against Babesia microti in several animal models of acute infection and in a single human case of relapsing babesiosis. Here, we report 5 cases of relapsing babesiosis treated with tafenoquine, including the previous case, and begin to define the conditions for optimal use of tafenoquine in relapsing babesiosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!